XML 31 R16.htm IDEA: XBRL DOCUMENT v2.3.0.15
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2011
EARNINGS PER SHARE 
EARNINGS PER SHARE

NOTE 12—EARNINGS PER SHARE

 

The following weighted average shares and share equivalents are used to calculate basic and diluted earnings per share for the three and nine months ended September 30, 2011 and 2010:

 

 

 

For the three months ended
September 30,

 

For the nine months ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

Weighted average number of shares outstanding used to calculate basic earnings per share

 

21,629,463

 

14,741,504

 

21,614,062

 

14,741,504

 

 

 

 

 

 

 

 

 

 

 

Dilutive securities

 

 

 

 

 

 

 

 

 

Unvested restricted shares

 

152,920

 

 

113,478

 

 

Weighted average number of shares and share equivaltents outstanding used to calculate diluted earnings per share

 

21,782,383

 

14,741,504

 

21,727,540

 

14,741,504

 

 

The assumed proceeds used in the treasury method used for calculating the dilutive impact of restricted stock awards includes the unrecognized compensation costs and excess tax benefits associated with the awards. Options issued under the 2010 Equity Incentive Plan to purchase 214,987 shares of common stock and 30,000 unvested restricted shares were outstanding during the three and nine months ended September 30, 2011, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive. There were no unvested restricted stock or stock option awards outstanding in the three and nine months ended September 30, 2010.

 

In January 2011, the underwriters of our initial public offering partially exercised their over-allotment option and the Company issued an additional 221,292 shares of our common stock. The over-allotment option was granted by the Company in connection with its initial public offering of 10,000,000 shares of common stock at $10.00 per share, which closed in December 2010. The Company offered 6,666,667 shares of common stock and selling stockholders offered 3,333,333 shares. With the addition of the over-allotment, net of selling stockholders, the Company sold 6,887,959 shares.